Myriam Curet Sells 421 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Tuesday, February 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $494.65, for a total value of $51,938.25.
• On Thursday, January 29th, Myriam Curet sold 126 shares of Intuitive Surgical stock. The shares were sold at an average price of $520.02, for a total transaction of $65,522.52.
• On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The shares were sold at an average price of $532.61, for a total transaction of $122,500.30.
• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The shares were sold at an average price of $559.90, for a total value of $58,229.60.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $478.60 on Friday. The stock’s fifty day moving average price is $543.41 and its two-hundred day moving average price is $510.30. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08. The firm has a market cap of $169.97 billion, a price-to-earnings ratio of 60.66, a P/E/G ratio of 3.84 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the firm posted $2.21 EPS. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares in the last quarter. State Street Corp raised its holdings in Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC raised its holdings in Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares during the last quarter. Capital World Investors boosted its position in Intuitive Surgical by 1.7% during the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after buying an additional 127,526 shares during the period. Finally, Norges Bank bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $2,856,987,000. Institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Company fundamentals: Intuitive beat January quarter revenue and EPS estimates and management highlighted continued procedure growth and da Vinci 5 adoption — a reminder the growth engine remains intact. Read More.
• Positive Sentiment: Analyst support: The broker community still leans positive overall (many Buy/Overweight ratings and several price-target raises), which provides a floor if execution continues.
• Neutral Sentiment: Technicals and flow: Traders are focused on the recent pullback vs. 50‑ and 200‑day moving averages; technical positioning can amplify near‑term moves even if fundamentals are stable. Read More.
• Neutral Sentiment: Short‑interest reports in recent feeds show anomalous zero/NaN values and should be treated with caution — they don’t appear to explain today’s move.
• Negative Sentiment: Insider selling: Multiple insider sales disclosed in early February (EVP Myriam Curet and VP Fredrik Widman) are prompting short‑term negative sentiment and may be interpreted as profit‑taking. Read More. Read More.
• Negative Sentiment: Valuation and recent underperformance: Coverage questioning whether ISRG is “priced for perfection” after a pullback and a ~13% three‑month decline is keeping some investors cautious despite the beat. Read More. Read More.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Raymond James Financial lifted their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Barclays set a $712.00 price target on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. UBS Group reaffirmed a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, January 21st. Finally, Royal Bank Of Canada boosted their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.